Mark Mallon, Chief Executive Officer at NEOGENOMICS INC (NEO), bought 17,000 shares at $30.63 ($521K) on 2021-12-06, disclosed to the SEC on 2021-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IRWD | SELL | 2020-02-25 | $186K | — | Filing → |